Navigation Links
Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at UBS 2007 Global Life Sciences Conference
Date:9/20/2007

SAN DIEGO, Sept. 20 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's President and CEO Theodore Schroeder will present the corporate overview on Thursday, September 27, 2007 at 11:30 am Eastern Time (8:30 am Pacific Time) during the UBS 2007 Global Life Sciences Conference in New York City.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at http://www.cadencepharm.com in the Investor Relations section. A replay of the webcast will be available approximately three hours following the live webcasts and will be archived for 30 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III product candidates in development, including intravenous acetaminophen (IV acetaminophen) for the treatment of acute pain and fever, and Omigard(TM) (omiganan pentahydrochloride 1% aqueous gel) for the prevention of catheter-related infections. For more information about Cadence's pipeline, visit http://www.cadencepharm.com.

Cadence(TM) and Omigard(TM) are trademarks of Cadence Pharmaceuticals, Inc.

Contacts: William R. LaRue Anna Gralinska

SVP & Chief Financial Officer Director, Investor
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
4. Wisconsin firms to present at Cleantech venture capital event
5. New Sonic Foundry search engine finds words, phrases in video presentations
6. Lone Wisconsin firm to present at InvestMidwest
7. Sonic Foundry creates search engine for 7,000 expert video presentations
8. InvestMidWest calls for business presentations
9. Wicab to present BrainPort at Boston conference
10. Three more Wisconsin firms to present at venture forum
11. Six Wisconsin firms to present at BIO Mid-America VentureForum

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... in German . , Whether it,s CD packaging, c...o Frequency Identification) are increasingly findi...ible to label objects or goods and identify them a...canner can read and process the data contained in ...der production conditions of up to 100 degrees Cel...
(Date:11/24/2009)...HEIM, Ontario, Nov. 24 D...ring the assets of Hyland Seeds, a division of Tho...of Hyland Seeds will further expand Dow AgroScienc...tes the introduction of SmartStax(TM) in 2010 ...chnology in corn in 2012. The transactional close ...
(Date:11/24/2009)... Nov. 24 /PRNewswire-Asia/ -- NOD Pharmaceuticals ...e (PTO) has allowed the patent application for,its..., NOD technology is a highly efficient appr...adhesive nano-particles to enable oral delivery of...echnology is a platform technology,that can be app...
(Date:11/24/2009)...ficacy endpoint has been met for patients with adv...,, QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ ... (the "Company"), a global biopharmaceutical compa...y announced positive efficacy data from a Phase 2 ...e, AEZS-108 (formerly AN-152), in patients with ad...
Breaking Biology Technology:Intelligence inside metal components 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...s Miller, CEO Workflow and Solutions Division, Sie...vent Keynote Speaker, PHILADELPHIA, Jan. 28 Rece...molecular imaging, molecular diagnostics,and infor...ls capable of,assessing and treating a growing num...ls provide physicians with an understanding of ind...
...AIN VIEW, Calif., Jan. 28 Clontech Laboratories,I... today announced the,imminent (February 20, 2008) ...featured in the April issue of Clontechniques, the...researchers at Stanford University and,licensed fr...technology to,regulate the amount of protein of in...
..., Pa., Jan. 28 BioTrends Research Group, Inc.,rel... Publication, a,syndicated report offering compreh... and bone and mineral metabolism in Chronic Kidney...o an online survey, completed by,305 clinical neph...e anemia market, the vast majority of nephrologist...
Other Biology Technology:The Dark Report and Siemens Introduce the World's First Integrated Molecular Summit 2The Dark Report and Siemens Introduce the World's First Integrated Molecular Summit 3The Dark Report and Siemens Introduce the World's First Integrated Molecular Summit 4Clontech Laboratories, Inc. Releases the ProteoTuner(TM) Systems 2BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2
(Date:11/26/2009)...antlers, red deer have been caught in the hunters,...much more than decorative. They are lethal weapons...rey, from The University of York, UK, has been int...er half a century and has become fascinated by the...anding collaboration with Tomas Landete-Castillejo...
(Date:11/26/2009)... Staphylococcus Aureus ) and other drug-resistant ...e plasma prototype devices have been developed to ... cocktails. , Two prototype devices have been de... skin (e.g. hands and feet) in hospitals and publi...and another to shoot bacteria-killing agents into ...
(Date:11/25/2009)... the Cell Death Research Laboratory in the Univers...rded the prestigious Johnson & Johnson Focused Fun... brain cell damage in Parkinson,s disease. The awa...pport of innovation and excellence in science, was...er this month at an event at the Hyatt Regency Hot...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2XTENT Announces Plan for NASDAQ Delisting and Filing of Certificate of Dissolution 53788 1XTENT Announces Plan for NASDAQ Delisting and Filing of Certificate of Dissolution 53788 2State Regulation of Massage Therapy Will Improve Public Health Safety 53783 1State Regulation of Massage Therapy Will Improve Public Health Safety 53783 2State Regulation of Massage Therapy Will Improve Public Health Safety 53783 3NeurogesX Announces New PDUFA Date for Qutenza 28TM 29 New Drug Application 13402 1NeurogesX Announces New PDUFA Date for Qutenza 28TM 29 New Drug Application 13402 2NeurogesX Announces New PDUFA Date for Qutenza 28TM 29 New Drug Application 13402 3NeurogesX Announces New PDUFA Date for Qutenza 28TM 29 New Drug Application 13402 4
... lowly sea slug, "Elysia chlorotica," may not seem... fooled: it behaves like a plant and is solar-powe... been studying these tiny creatures for the past d...niversities, has identified a possible cause of th...sor James Manhart is a member of a research group ...
...hose who consume fewer calories during flu season ...s, according to research by Michigan State Univers...dner. , In a study published in the November issu...at mice with a calorie-restricted diet were more l...n than mice with a normal diet. Caloric restrictio...
...nanced by NWO, has discovered a new mechanism for ...y hot and acidic conditions. The results of the re...o the functioning of the human body. The research ...e of the American National Academy of Sciences. Th... a Rubicon grant from NWO in 2006 to gain experien...
Other Biology News:Solar-powered sea-slugs live like plants, prof says 2Feed a cold, feed a fever: Research shows calorie cut makes it harder to fight flu 2Proteins strangle cell during division 2
Acridinium NHS ester from Cayman Chemical
...olor real-time PCR detection system holds 48 x 0.2... LEDs independently excites fluorescence (470-500 ...des detects emitted light (523-543 nm and 540-700 ...e Peltier heat pumps provide superb thermal perfor...
... making flow cytometry accessible to anyone in the... latest addition to Guavas on-demand microcapillar... easy to use, surprisingly affordable, very compac...or detection. The Guava EasyCyte Mini has all of t...
...t designed to hold up to 6 strain chambers with pr...asy to use design ensures that cells grow over lon...r compression. This unit allows you to control the...unique strain settings. The instrument fits in a s...
Biology Products: